These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Miliary tuberculosis as a complication of BCG immunotherapy in cancer of the bladder. Case report].
    Author: Arrese M, Ebel L, Hofmann E, Gaete P, Jara A, Cabrera K, Araos F, Del Río P, Valdivieso V.
    Journal: Rev Med Chil; 1992 Aug; 120(8):910-3. PubMed ID: 1340967.
    Abstract:
    Intravesical administration of BCG may be used as an ancillary immunotherapy after endoscopic resection for cancer of the bladder. Local side effects are usually mild. Here is reported a patient who developed miliary tuberculosis after this form of therapy. Radiologic studies of the thorax and liver biopsy confirmed the diagnosis. The patient recovered after treatment with anti-tuberculosis drugs (TA-81 scheme). Epithelial trauma may be invoked as an alteration facilitating this complication. Although it develops infrequently, patients with bladder cancer treated with BCG must be monitored for this complication.
    [Abstract] [Full Text] [Related] [New Search]